$KMPH $SUPN Qelbree acceptance from the young parents is exploding. Parents are choosing non stimulant Qelbree first for obvious reasons for their children. If you are an investor it's best to own both. Qelbree continues to expand its base of prescribers, with approximately 9,276 prescribers in the second quarter of 2022, up from 6,900 prescribers from the first quarter of 2022.”
3